CDH1 and ovarian cancer: Based on these results, this study concluded that both claudin-3 and claudin-4 inhibit tumor growth and metastatic potential in vivo through the maintenance of E-cadherin expression and suppression of β-catenin signaling, suggesting a tumor suppressive role for claudin-3 and claudin-4 in ovarian cancer.